{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:32:37Z","timestamp":1759602757729},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.gastrohep.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,7,14]],"date-time":"2012-07-14T23:45:04Z","timestamp":1342309504000},"page":"560-566","source":"Crossref","is-referenced-by-count":11,"title":["Thalidomide-induced acute cholestatic hepatitis: Case report and review of the literature"],"prefix":"10.1016","volume":"35","author":[{"given":"Filipe","family":"Vilas-Boas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Sobrinho Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2012.05.007_bib0005","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(97)09038-7","article-title":"Thalidomide: was the tragedy preventable?","volume":"351","author":"Dally","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.7326\/0003-4819-127-10-199711150-00023","article-title":"Preparing for thalidomide's comeback","volume":"127","author":"Vanchieri","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0015","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1359-6446(04)03307-0","article-title":"Thalidomide as a novel therapeutic agent: new uses for an old product","volume":"10","author":"Teo","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-540-85772-3_9","article-title":"Firstline treatment and maintenance in newly diagnosed multiple myeloma patients","volume":"183","author":"Roussel","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0030","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0035","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1182\/blood-2008-04-149427","article-title":"Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial","volume":"112","author":"Palumbo","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.blre.2010.10.003","article-title":"Management of older patients with multiple myeloma","volume":"25","author":"Gay","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","article-title":"Thalidomide: a review of approved and investigational uses","volume":"25","author":"Matthews","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00002018-200124020-00002","article-title":"Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing","volume":"24","author":"Clark","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0055","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510260319","article-title":"Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis","volume":"26","author":"Maria","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jhep.2011.02.007","article-title":"Causality assessment methods in drug induced liver injury: strengths and weaknesses","volume":"55","author":"Garcia-Cortes","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.clpt.2006.02.012","article-title":"Drug-induced liver injury: Hy's rule revisited","volume":"79","author":"Bjornsson","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0080","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.22272","article-title":"Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals","volume":"47","author":"Lammert","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0085","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/hep.21424","article-title":"Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry","volume":"44","author":"Andrade","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1476-5381.1965.tb02054.x","article-title":"The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species","volume":"25","author":"Schumacher","year":"1965","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1099-0461(2000)14:3<140::AID-JBT3>3.0.CO;2-P","article-title":"Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients","volume":"14","author":"Teo","year":"2000","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0100","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0306-3623(95)00019-W","article-title":"Exacerbation of acetaminophen hepatotoxicity by thalidomide and protection by nicotinic acid amide","volume":"26","author":"Kroger","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2010.04320.x","article-title":"Review article: drug-induced liver injury in clinical practice","volume":"32","author":"Bjornsson","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0110","first-page":"w13080","article-title":"Liver injury caused by drugs: an update","volume":"140","author":"Stirnimann","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0115","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1592\/phco.26.7.1018","article-title":"Thalidomide-induced severe hepatotoxicity","volume":"26","author":"Hanje","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0120","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4065\/82.5.638","article-title":"Thalidomide-induced fulminant hepatic failure","volume":"82","author":"Hamadani","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajh.1062","article-title":"Thalidomide-associated hepatitis: a case report","volume":"66","author":"Fowler","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/annonc\/mdg095","article-title":"Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma","volume":"14","author":"Trojan","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00277-008-0559-8","article-title":"Hepatotoxicity as a rare but serious side effect of thalidomide","volume":"88","author":"Levesque","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gastrohep.2012.05.007_bib0145","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00280-008-0891-7","article-title":"Thalidomide-induced severe hepatotoxicity","volume":"63","author":"Dabak","year":"2009","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570512001744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570512001744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T04:50:21Z","timestamp":1542862221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570512001744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0210570512001744"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2012.05.007","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}